# Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

> **NCT04094272** · — · COMPLETED · sponsor: **Kantonsspital Olten** · enrollment: 49 (actual)

## Conditions studied

- Pulmonary Artery Hypertension
- Chronic Hepatitis c

## Interventions

- **DIAGNOSTIC_TEST:** transthoracic doppler-echocardiography (TTE)

## Key facts

- **NCT ID:** NCT04094272
- **Lead sponsor:** Kantonsspital Olten
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094272, "Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04094272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*